Associated Papers
ASXL1 and STAG2 are common mutations in GATA2 deficiency patients with bone marrow disease and myelodysplastic syndrome.
West RR et al.
Blood Advances, 2022
GATA2 deficiency syndrome: A decade of discovery.
Homan CC et al.
Human Mutation, 2021
Diagnosing MonoMAC Syndrome in GATA2 Germline Mutated Myelodysplastic Syndrome via Next-Generation Sequencing in a Patient with Refractory and Complex Infection: Case Report and Literature Review.
Shen Y et al.
Infection and Drug Resistance, 2021
GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia.
Ganapathi KA et al.
Blood, 2015
GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.
Spinner MA et al.
Blood, 2014
Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation.
West RR et al.
Haematologica, 2014
Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset.
Mace EM et al.
Blood, 2013
Marked genetic heterogeneity in familial myelodysplasia/acute myeloid leukaemia.
Holme H et al.
British Journal of Haematology, 2012
Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome.
Hsu AP et al.
Blood, 2011
Select a paper to view details